Plutux
$12.30
+0.82%
2026-09-04 13:06:06 EDT+$0.10
Servicios financieros
Empresas pantalla
NASDAQ
Negociación activa

Aimei Health Technology Co., Ltd. actualmente carece de operaciones comerciales sustanciales. Su propósito principal es llevar a cabo una combinación estratégica de ...

Evolución del precio

$12.30
+0.82%+$0.10
Máximo
Mínimo
Máx. 52s-90.6%
Vol. rel.
Intervalo
Rango50m
VolumenSMA5SMA10
Aimei Health Technology Co., Ltd (NASDAQ: AFJK) is a special purpose acquisition company (SPAC) incorporated as a Cayman Islands exempted company on April 27, 2023, and based in New York, New York. The company was established with the sole purpose of effecting a merger, share exchange, asset acquisition, share purchase, ...Aimei Health Technology Co., Ltd (NASDAQ: AFJK) is a special purpose acquisition company (SPAC) incorporated as a Cayman Islands exempted company on April 27, 2023, and based in New York, New York. The company was established with the sole purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more target businesses. Its focus areas include the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries, reflecting a strategic interest in healthcare and life sciences sectors. The company went public on January 22, 2024, after pricing its initial public offering (IPO) in December 2023, raising $60 million. As a blank check company, it currently has no revenue-generating operations, and its financials reflect pre-combination characteristics: zero revenue, no gross or operating margins, minimal assets, and a modest market capitalization of approximately $73.8 million. The stock has traded in a wide range of $6.75 to $130.37, indicating significant volatility. Key financial metrics include a price-to-book ratio of 1.551, a price-to-earnings ratio of 71.957 (reflecting small positive net income from trust interest), and a negative enterprise value-to-sales ratio due to lack of revenue. The company has minimal liquidity, with a current ratio of 0.005, and relies on its trust account to fund future business combinations. Leadership is lean, with CEO Junheng Xie, who also serves as Secretary and Director, and CFO Heung Ming Wong. The company has only 2 employees, both likely part of the management team. A significant development is the definitive business combination agreement with United Hydrogen Group Inc., indicating a planned merger that could transform the company into an operating business in the hydrogen energy sector. This move aligns with global trends toward clean energy and could provide a pathway to value creation for shareholders. Given its SPAC structure, the company faces risks typical of such entities, including the need to complete a business combination within a specified timeframe, potential shareholder redemptions, and regulatory scrutiny. However, its targeted industries and management's experience may offer opportunities for growth. As of the latest data, the company is actively trading on the NASDAQ Global Market, and investors are closely watching its progress toward finalizing the merger with United Hydrogen Group.
Fundación
2023
Empleados
2
CEO
Junheng Xie
Nombre completo
Aimei Health Technology Co., Ltd
Sector
Servicios financieros
Industria
Empresas pantalla
ROE
2.49%
Capitalización
$0.04B
Ratio corriente
0.01
WACC
7.03%
ROIC
16.74%

Información de contacto

212 845 9945
10 East 53rd Street, New York City, NY 10022

Acciones relacionadasShell Companies

Ver todas las acciones de EE. UU.

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal

© Plutux Technology Limited 2026